 This is a single-center, open-label, safety and tolerability study. Based on findings in the literature from both animal research and clinical observations with ICH intracerebral hemorrhage associated with TBI traumatic brain injury, this study will begin to look at the safety, tolerability, as well as potential effectiveness, of conivaptan to reduce CE cerebral edema in patients with non-traumatic ICH. 